The sedative that caused a global medical catastrophe
In short: In 1957, a new drug promised to cure morning sickness. It was hailed as virtually harmless because it failed to kill test animals. Instead, it caused thousands of infants to be born with severe birth defects, forever changing how the world regulates medicine.
Developed in the mid-1950s by the West German company Chemie Grünenthal GmbH, thalidomide was originally intended as a sedative or tranquilizer. Because it was found to be 'virtually impossible' to give a lethal dose to test animals during LD50 testing, researchers deemed the compound safe for human consumption. By July 1956, it was licensed in Germany for over-the-counter sale, requiring no doctor's prescription. The compound was also marketed to treat common ailments like the flu and pneumonia. It was noted for its ability to induce drowsiness and sleep. The drug was first introduced to the public on October 1, 1957.
The drug's reach was massive. At least 37 distinct commercial titles were used by 14 drug firms to sell thalidomide across 46 nations during the mid-1950s. British consumers purchased the drug via labels such as Asmaval and Distaval, while marketing materials insisted that expectant mothers and breastfeeding women could use it without risk. While the US Food and Drug Administration (FDA) rejected it for general marketing, an early-stage clinical trial still distributed the compound to 1,200 physicians and approximately 20,000 patients, 600 of whom were pregnant. The company Chemie Grünenthal GmbH held the original license for the compound. It was sold as a treatment for nausea in early pregnancy. The Distillers Company (Biochemicals) Ltd produced it in the United Kingdom.
The tragedy took five years to be fully connected to pregnancy. The fallout was so severe that it fundamentally restructured the pharmaceutical industry. It led to the implementation of much tighter drug testing protocols and mandatory reporting of side effects. Today, thalidomide remains a primary case study in the necessity of rigorous clinical oversight and the dangers of assuming safety based solely on acute toxicity in animals. The scandal resulted in a permanent shift in how new medicines are regulated globally. It serves as a reminder of the complexities in modern drug discovery. The industry now faces ongoing challenges in identifying new drug targets.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Thalidomide: The Chemistry Mistake That Killed Thousands of Babies
- Also: Thalidomide | Science Museum
To cite this card, link to https://intellectplus.co.uk/app/science-thalidomide-the-chemistry-mistake-that-killed-thousands-of-b.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Science · Latest · A–Z · All topics
